CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)
Clinical trial NCT03904719 · UNKNOWN
Trial details
- NCT number
- NCT03904719
- Sponsor
- AnewPharma
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-18
- Primary completion
- 2021-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.